Medicare Enrolled

Dr. Obeidurahman Rehmani, M.D.

Neurology · Plano, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1600 COIT RD STE 208, Plano, TX 75075
9038935141
In practice since 2011 (15 years)
NPI: 1619275963 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rehmani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rehmani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rehmani

Dr. Obeidurahman Rehmani is a neurology in Plano, TX, with 15 years in practice. Based on federal Medicare data, Dr. Rehmani performed 429 Medicare services across 387 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rehmani received a total of $11,195 from 54 pharmaceutical and/or device companies across 517 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rehmani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ 429 Medicare services$ $11,195 industry payments

Medicare Practice Summary

Medicare Utilization ↗
429
Medicare services
Bottom 46% in TX for neurology
387
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)113$79$181
Office visit, established patient, complex (40-54 min)70$121$255
Office visit, established patient (20-29 min)61$56$129
Hospital follow-up visit, moderate complexity45$59$107
Initial hospital admission, high complexity42$129$263
New patient office visit, complex (60-74 min)34$144$312
Measurement of brain wave activity (eeg), awake and drowsy26$39$82
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or15$24$46
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional12$90$193
Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional11$232$455
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,195
Total received (2018-2024)
Avg $1,599/year across 7 years
Top 26% in TX for neurology
54
Companies
517
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,195 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,724
2023
$1,127
2022
$1,587
2021
$1,239
2020
$1,681
2019
$1,390
2018
$2,448

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$1,636
LivaNova USA, Inc.
$1,517
Eisai Inc.
$616
Avanir Pharmaceuticals, Inc.
$589
Supernus Pharmaceuticals, Inc.
$579
Lilly USA, LLC
$456
Celgene Corporation
$412
Amgen Inc.
$404
ABBVIE INC.
$383
Genentech USA, Inc.
$315
ACADIA Pharmaceuticals Inc
$308
PFIZER INC.
$304
Neurelis, Inc.
$274
Biogen, Inc.
$267
Novartis Pharmaceuticals Corporation
$257
E.R. Squibb & Sons, L.L.C.
$218
SK Life Science, Inc.
$193
GENZYME CORPORATION
$189
Allergan, Inc.
$180
EISAI INC.
$177
Lundbeck LLC
$161
Amneal Pharmaceuticals LLC
$152
Allergan Inc.
$145
Biohaven Pharmaceutical Holding Company Ltd.
$138
Kyowa Kirin, Inc.
$99
Mallinckrodt LLC
$90
Janssen Pharmaceuticals, Inc
$82
CSL Behring
$81
Alexion Pharmaceuticals, Inc.
$79
Teva Pharmaceuticals USA, Inc.
$79
EMD Serono, Inc.
$68
ARGENX US, INC.
$65
AstraZeneca Pharmaceuticals LP
$61
Neurocrine Biosciences, Inc.
$53
Grifols USA, LLC
$51
Marinus Pharmaceuticals, Inc.
$50
Alnylam Pharmaceuticals Inc.
$48
Adamas Pharmaceuticals, Inc.
$44
Biohaven Pharmaceuticals, Inc.
$37
JAZZ PHARMACEUTICALS INC.
$37
AbbVie Inc.
$36
Merz Pharmaceuticals, LLC
$30
Mallinckrodt Hospital Products Inc.
$29
Greenwich Biosciences, Inc.
$29
CATALYST PHARMACEUTICALS, INC.
$28
BIOTRONIK NRO, Inc.
$23
Aucta Pharmaceuticals, Inc.
$20
HOSPIRA, INC.
$20
IMPEL PHARMACEUTICALS INC.
$18
PORTOLA PHARMACEUTICALS, INC.
$17
Acorda Therapeutics, Inc
$16
Sumitomo Pharma America, Inc.
$14
Impax Laboratories, Inc.
$13
Mallinckrodt Enterprises LLC
$11
Top 3 companies account for 33.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · Aimovig · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · Briviact · COMIRNATY · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LYRICA · Leqembi · MAVENCLAD · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · Ocrevus · PANZYGA · Ponvory · Prospera · QULIPTA · REYVOW · RYTARY · SKYCLARYS · SPINRAZA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · Xeomin · ZEPOSIA · ZTALMY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,610 per 100 Medicare services performed
Looking for a neurology in Plano?
Compare neurologys in the Plano area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
225
Per 100K population
20.2
County median income
$117,588
Nearest hospital
MEDICAL CITY PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rehmani is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rehmani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rehmani performed 113 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rehmani receive payments from pharmaceutical companies?
Yes. Dr. Rehmani received a total of $11,195 from 54 companies across 517 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rehmani's costs compare to other neurologys in Plano?
Dr. Rehmani's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rehmani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →